Cargando…

IgG1-Dominant Antibody Response Induced by Recombinant Trimeric SARS-CoV-2 Spike Protein with PIKA Adjuvant

Recombinant trimeric SARS-CoV-2 Spike protein with PIKA (polyI:C) adjuvant induces potent and durable neutralizing antibodies that protect against multiple SARS-CoV-2 variants. The immunoglobulin subclasses of viral-specific antibodies remain unknown, as do their glycosylation status on Fc regions....

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jingxia, Mai, Xinjia, He, Yu, Zhu, Chenxi, Zhou, Dapeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144704/ https://www.ncbi.nlm.nih.gov/pubmed/37112739 http://dx.doi.org/10.3390/vaccines11040827

Ejemplares similares

Potent Neutralization Antibodies Induced by a Recombinant Trimeric Spike Protein Vaccine Candidate Containing PIKA Adjuvant for COVID-19
por: Tong, Jiao, et al.
Publicado: (2021)

Fast and long-lasting immune response to S-trimer COVID-19 vaccine adjuvanted by PIKA
por: Liu, Yuan, et al.
Publicado: (2021)

Anti-spike S1 IgA, anti-spike trimeric IgG, and anti-spike RBD IgG response after BNT162b2 COVID-19 mRNA vaccination in healthcare workers
por: Salvagno, Gian Luca, et al.
Publicado: (2021)

Transient IgA, steady IgG?
por: Berthold, Dorothée L., et al.
Publicado: (2020)

IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection
por: Choudhary, Hari Ram, et al.
Publicado: (2021)

IgG Western Blot for Confirmatory Diagnosis of Equivocal Cases of Toxoplasmosis by EIA-IgG and Fluorescent Antibody Test
por: Khammari, Imen, et al.
Publicado: (2013)

Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvants
por: Liu, Haitao, et al.
Publicado: (2021)

Trimer IgG and neutralising antibody response to COVID-19 mRNA vaccination in individuals with sarcoidosis
por: Vagts, Christen L., et al.
Publicado: (2023)

Prevention of Dominant IgG Adsorption on Nanocarriers in IgG‐Enriched Blood Plasma by Clusterin Precoating
por: Prozeller, Domenik, et al.
Publicado: (2019)

Unusual Multiorgan Immunoglobulin G4 (IgG4) Inflammation: Autoimmune Pancreatitis, Mikulicz Syndrome, and IgG4 Mastitis
por: Dítě, Petr, et al.
Publicado: (2013)

MONOCLONAL PRODUCTION OF BOTH IgM AND IgG1 ANTIHAPTEN ANTIBODY
por: Press, Joan L., et al.
Publicado: (1973)

Correlation between Anti-SARS-CoV-2 Total Antibodies and Spike Trimeric IgG after BNT162b2 Booster Immunization
por: Salvagno, Gian Luca, et al.
Publicado: (2022)

COVID-19 IgG/IgM antibody testing in Los Angeles County, California
por: Ahmad, Khadije, et al.
Publicado: (2020)

Macro- and Micro-Heterogeneity of Natural and Recombinant IgG Antibodies
por: Beck, Alain, et al.
Publicado: (2019)

Differential abundance of IgG antibodies against the spike protein of SARS-CoV-2 and seasonal coronaviruses in patients with fatal COVID-19
por: Smit, Wouter L., et al.
Publicado: (2023)

Coronavirus Disease 2019-Related Alterations of Total and Anti-Spike IgG Glycosylation in Relation to Age and Anti-Spike IgG Titer
por: Schwedler, Christian, et al.
Publicado: (2022)

Effectiveness of Strongyloides Recombinant IgG Immunoreactive Antigen in Detecting IgG and IgG4 Subclass Antibodies for Diagnosis of Human Strongyloidiasis Using Rapid Immunochromatographic Tests
por: Boonroumkaew, Patcharaporn, et al.
Publicado: (2020)

Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies
por: Takahashi, Maika, et al.
Publicado: (2022)

Selection of monoclonal antibody E48 IgG or U36 IgG for adjuvant radioimmunotherapy in head and neck cancer patients.
por: de Bree, R., et al.
Publicado: (1997)

Natural IgG antibodies to β amyloid are decreased in patients with Parkinson’s disease
por: Paganelli, Roberto, et al.
Publicado: (2023)

IgG4-associated orbital and ocular inflammation
por: Lee, Cecilia S, et al.
Publicado: (2015)

QUANTITATIVE STUDIES ON TUMOR ENHANCEMENT IN MICE : I. ENHANCEMENT OF SARCOMA I INDUCED BY IgM, IgG1, AND IgG2
por: Rubinstein, Pablo, et al.
Publicado: (1974)

Seroprevalence of CMV IgG and IgM in Korean women of childbearing age
por: Choi, Rihwa, et al.
Publicado: (2021)

IgG4-Related Sclerosing Mesenteritis
por: Lee, Seok Joo, et al.
Publicado: (2016)

Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels
por: MacGlashan, Donald, et al.
Publicado: (2021)

Association of dengue infection with anti-alpha-gal antibodies, IgM, IgG, IgG1, and IgG2
por: Olajiga, Olayinka M., et al.
Publicado: (2022)

Increased IgG but normal IgA anti-pneumococcal protein antibodies in lung of HIV-infected adults()
por: Collins, Andrea M., et al.
Publicado: (2013)

RBD and Spike DNA-Based Immunization in Rabbits Elicited IgG Avidity Maturation and High Neutralizing Antibody Responses against SARS-CoV-2
por: da Costa, Hernan H. M., et al.
Publicado: (2023)

IgG Against Human Betacoronavirus Spike Proteins Correlates With SARS-CoV-2 Anti-Spike IgG Responses and COVID-19 Disease Severity
por: Wang, Jiong, et al.
Publicado: (2022)

Anti-SARS-CoV-2 spike IgG antibodies prevalence: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Thirteen-Valent Pneumococcal Conjugate Vaccine–Induced Immunoglobulin G (IgG) Responses in Serum Associated With Serotype-Specific IgG in the Lung
por: Mitsi, Elena, et al.
Publicado: (2021)

Specific Antibody Deficiency in Adult Patients With IgG or IgG Subclass Deficiency
por: Kim, Joo-Hee, et al.
Publicado: (2020)

Survival of Recombinant Monoclonal Antibodies (IgG, IgA and sIgA) Versus Naturally-Occurring Antibodies (IgG and sIgA/IgA) in an Ex Vivo Infant Digestion Model
por: Lueangsakulthai, Jiraporn, et al.
Publicado: (2020)

Serologic Tests of IgG and IgM Antibodies and IgG Avidity for Diagnosis of Ocular Toxoplasmosis
por: Rahimi-Esboei, Bahman, et al.
Publicado: (2018)

Co-existing ligneous conjunctivitis and IgG4-related disease
por: Chiang, Wei-Yu, et al.
Publicado: (2016)

Peak IgG antibody titers against SARS-CoV-2 spike protein following immunization with the Pfizer/BioNTech BNT162b2 vaccine
por: Kobashi, Yurie, et al.
Publicado: (2022)

The antiinflammatory activity of IgG: the intravenous IgG paradox
por: Nimmerjahn, Falk, et al.
Publicado: (2007)

Evaluation of Anti-Toxoplasma IgG, IgM, and IgA in Mothers with Spontaneous Abortion in Zanjan, Northwest Iran
por: Amin, Abbas, et al.
Publicado: (2012)

Serum IgG4 levels outperform IgG4/IgG RNA ratio in differential diagnosis of IgG4-related disease
por: Schulte, Lucas A., et al.
Publicado: (2020)

Recombinant AAV Vectors for Enhanced Expression of Authentic IgG
por: Fuchs, Sebastian P., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7uhul6hbm19nhbac81i4bi8996